Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Claudia Mailaender, PhD"'
Autor:
Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 6, Pp 100787- (2023)
Immunoglobulin E (IgE) plays a critical role in the allergen-initiated inflammatory pathway and thus serves as a viable therapeutic target in allergic or IgE-mediated diseases such as asthma. Omalizumab, an anti-IgE biologic, has been approved in the
Externí odkaz:
https://doaj.org/article/1ee3faee6f3546769426d58a00e6db64